Home › Companies › G1 Therapeutics Inc.

G1 Therapeutics Inc. proxy voting records

How asset managers voted at G1 Therapeutics Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.

• CUSIP issuer number3621LQ
• SEC CIK1560241

Recent shareholder votes

• June 13, 2024 annual meeting (2023-2024 proxy season): 5 items in G1 Therapeutics Inc.'s official results (Form 8-K, filed June 14, 2024); lowest support 78% of votes cast (Elect Director: Cynthia L. Flowers). Full results and how funds voted.

Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.

Proxy seasons

Earlier seasons list this company under the name G1 THERAPEUTICS INC., as its holders filed it.

Explore G1 Therapeutics Inc. in the interactive database

The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. This page is rebuilt weekly; built November 9, 2026.